Results 41 to 50 of about 1,077,721 (136)
Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial [PDF]
Alcohol use disorder is one of the most prevalent mental health disorders worldwide, treatment options are limited, and relapse rates are high. There remains an urgent need for effective treatments. Research involving the therapeutic potential of classic
Gruppo, Katherine
core +1 more source
Modalities for Psilocybin-Assisted Psychotherapy: A Review
This paper will review the current literature on modalities used or proposed for psilocybin-assisted psychotherapy. Modalities have been offered for the treatment of depression, addiction, and the demoralisation of long term AIDS survivors.
Haworth, Nicole
core
Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health
Richard J. Zeifman +7 more
doaj +1 more source
Abstract Background and aims Australia recently down‐scheduled and authorised psychedelic‐assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness.
Sarah J. Catchlove +3 more
wiley +1 more source
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve +6 more
wiley +1 more source
Education for Healthcare Providers: Psilocybin-Assisted Psychotherapy [PDF]
Psilocybin-assisted psychotherapy is emerging as a promising therapeutic modality for addressing psychological distress in psychiatric and palliative care settings.
Carlson, Chelsi
core +1 more source
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Mental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a ...
Eduardo Ekman Schenberg
doaj +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Obsessive–Compulsive Disorder: Comorbidity, Biomarkers, Circuits, and Treatment Strategies
OCD has a high comorbidity with other psychiatric conditions, among which anxiety is the most frequent one. The shared genetic biomarkers and common neural circuits underlying the co‐occurrence of OCD and anxiety pave a new path for understanding the pathogenic mechanism of OCD and suggest tailored and integrative treatment therapies for OCD from the ...
Xiao‐Yang Zhang +9 more
wiley +1 more source
The influence of psilocybin on subconscious and conscious emotional learning
Summary: Serotonergic psychedelics hold promise as a treatment modality for various psychiatric disorders and are currently applied in psychedelic-assisted psychotherapy.
Andrea F. Casanova +5 more
doaj +1 more source

